We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
The unprecedented nature of the current financial crisis has brought significant attention to the use of over-the-counter (OTC) derivatives by all segments of the financial services market, including insurance companies
